|
US 11,833,194 B2 |
|
| Peptides and combination of peptides for use in immunotherapy against various cancers |
| Andrea Mahr, Tuebingen (DE); Toni Weinschenk, Aichwald (DE); Colette Song, Ostfildern (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); and Harpreet Singh, Munich (DE) |
| Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on May 28, 2021, as Appl. No. 17/333,929. |
| Application 17/333,929 is a continuation of application No. 16/705,042, filed on Dec. 5, 2019, granted, now 11,433,124. |
| Application 16/705,042 is a continuation of application No. 16/408,653, filed on May 10, 2019, granted, now 10,525,116, issued on Jan. 7, 2020. |
| Application 16/408,653 is a continuation of application No. 16/116,323, filed on Aug. 29, 2018, granted, now 10,342,859, issued on Jul. 9, 2019. |
| Application 16/116,323 is a continuation of application No. 15/374,882, filed on Dec. 9, 2016, granted, now 10,179,165, issued on Jan. 15, 2019. |
| Claims priority of provisional application 62/266,233, filed on Dec. 11, 2015. |
| Prior Publication US 2021/0290744 A1, Sep. 23, 2021 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. A61K 39/00 (2006.01); C07K 7/08 (2006.01); C12N 15/115 (2010.01); C12N 5/0783 (2010.01); C07K 14/71 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); C12Q 1/6886 (2018.01); C07K 16/18 (2006.01); G01N 33/574 (2006.01); C07K 14/47 (2006.01); C07K 16/30 (2006.01); C07K 7/06 (2006.01); C07K 14/72 (2006.01); C12N 9/12 (2006.01); C07K 16/38 (2006.01); C07K 14/81 (2006.01); C07K 16/40 (2006.01); C12N 9/02 (2006.01); C07K 14/705 (2006.01); G16B 25/00 (2019.01); G16B 25/10 (2019.01); A61K 35/17 (2015.01); A61K 38/00 (2006.01) |